Does lipoprotein(a) predict risk in type 2 diabetes?

European Journal of Clinical Investigation

Volumn 36, Issue 2, 2006, Pages 67-68

  Kostner, K M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; NICOTINIC ACID; OMEGA 3 FATTY ACID; PALM OIL;

APHERESIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEART DISEASES; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, LDL; RISK FACTORS;

EID: 33645048988     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01605.x     Document Type: Note

References (10)

1. Berg K A new serum type system in man: the Lp system Acta Pathol Microbiol Scand 1963 59 362 72
2. Kostner KM Kostner GM Lipoprotein (a): still an enigma? Curr Opin Lipidol 2002 13 391 6
3. Danesh J Collins R Peto R Lipoprotein(a) and coronary artery disease: meta-analysis of prospective studies Circulation 2000 102 1082 5
4. Tsimikas S Brilakis ES Miller ER McConnell JP Lennon RJ Kornman KS et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease N Engl J Med 2005 353 46 57
5. Ridker PM Hennekens CA Stampfer MJ A prospective study of Lp(a) and the risk of myocardial infarction JAMA 1993 270 2195 9
6. Marcovina S Koschinsky ML Albers J Skarlatos S Report of the National Heart Lung and Blood Institute workshop on lipoprotein(a) and cardiovascular disease. Recent advances and future directions Clin Chem 2003 49 1788 96
7. Schlueter W Keilani T Batlle DC Metabolic effects of ACE inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril Am J Cardiol 1993 72 37 44
8. Hoffmann U Derfler K Haas M Stadler A Brady TJ Kostner K Effects of combined low-density lipoprotein apheresis and aggressive statin therapy on coronary calcified plaque as measured by computed tomography Am J Cardiol 2003 91 461 4
9. Saely CH Saely L Koch F Schmid T Marte S Aczel P et al. Lipoprotein(a), type 2 diabetes, and vascular risk in coronary patients Eur J Clin Invest 2006 36 91 97
10. Kostner K Clodi M Bodlaj G Watschinger B Hörl W Derfler K et al. Decreased urinary apo(a) excretion in patients with impaired renal function Eur J Clin Invest 1998 28 447 52